Fenix Charity Donates Advanced Neonatal Equipment to Klaipėda University Hospital
The Fenix Charity foundation has donated advanced neonatal medical equipment to the Neonatal Department of Klaipėda University Hospital, continuing its commitment to supporting healthcare institutions across Lithuania.
The foundation's mission is made possible through the ongoing support of the Lithuanian electronic money institution Walletto. Thanks to Walletto's financial contribution, Fenix Charity donated an Infant Warmer i manufactured by Atom Medical (Japan) and a Medin NC3 positive airway pressure support system with a Wilamed AIRcon humidifier manufactured by Medin Medical (Germany). The new equipment will help healthcare professionals provide specialised care to premature and critically ill newborns from the very first moments of life.
"Our foundation's mission is to support children and help create better opportunities for their future. We see that hospitals need modern medical equipment to ensure the highest quality of care for newborns, especially those born prematurely or in critical condition. We are proud to donate equipment that can make a real difference from the very first moments of a child's life. We sincerely hope this contribution will help healthcare professionals continue saving lives and provide even more children with the healthiest possible start in life," said Agata Baj, Director of Fenix Charity.
Approximately 2,000 babies are born at Klaipėda University Hospital each year, including around 80 premature newborns. As the largest neonatal care centre in Western Lithuania, the hospital provides specialised treatment not only for babies born in Klaipėda but also for newborns transferred from across the region.
"For the past three years, Walletto has proudly supported Lithuanian hospitals together with Fenix Charity by donating modern medical equipment that helps healthcare professionals save the lives of newborns. For us, this is more than philanthropy—it is an investment in the future. We believe every child deserves the best possible start in life, and we are proud to contribute to strengthening Lithuania's healthcare system while supporting the dedicated medical professionals who care for the country's youngest patients every day," said Miglė Soltysiak, CEO of Walletto.
The Infant Warmer i helps maintain a stable body temperature immediately after birth while enabling medical staff to monitor vital signs and perform essential procedures. The Medin NC3 respiratory support system provides gentle, non-invasive breathing assistance for premature and critically ill newborns, ensuring safer and more effective treatment.
Infant warmers and non-invasive respiratory support systems are among the most essential types of equipment required in neonatal intensive care units. Used daily in the treatment of premature and critically ill infants, these systems play a vital role in stabilising newborns immediately after birth and supporting them through the most critical stages of their care. By responding to hospitals' most urgent needs, Fenix Charity ensures that its targeted donations have a direct and lasting impact on patient care."Every day we care for our smallest and most vulnerable patients, and modern medical equipment is essential to providing safe and high-quality treatment. The infant warmer will enable our specialists to maintain a newborn's body temperature while performing critical procedures from the very first moments of life. The respiratory support system will expand our ability to safely and effectively treat premature and critically ill babies. We sincerely thank Fenix Charity and Walletto for this meaningful contribution to the health and future of our youngest patients," said Rūta Šuipienė, Head of the Neonatology Centre at Klaipėda University Hospital.
Over the past three years, Fenix Charity has supported five hospitals in Lithuania and Latvia by donating essential neonatal medical equipment. These contributions have helped healthcare professionals provide specialised care for premature and critically ill newborns, improved access to advanced treatment, and given more children the best possible start in life.